Faster, More Accurate Cancer Treatments on Horizon in Japan With Official Approval of Elekta AB (SE:EKTAB)'s Agility Beam-shaping Innovation for Radiation Therapy

7/31/2012 10:15:03 AM

TOKYO--(BUSINESS WIRE)--Regulatory News: Following U.S. and European approvals of Elekta’s Agility (http://www.elekta.com/agility)™* MLC, Japan will join the international community of users of the beam-shaping device with the country’s PMDA clearance of Agility. The approval paves the way for the first clinical use of Agility in Japanese healthcare centers. Using a combination of 160 high-resolution tungsten leaves and dramatically faster leaf movement, Agility promises a new level of precision and delivery speed in radiation therapy treatments for patients with cancer.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• Medical Dev. & Diag. - Approvals

• Medical Devices